Harvard Bioscience, Inc. (NASDAQ:HBIO) Sees Significant Growth in Short Interest

Harvard Bioscience, Inc. (NASDAQ:HBIO) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 654,400 shares, a growth of 22.8% from the December 31st total of 533,100 shares. Based on an average daily volume of 166,000 shares, the days-to-cover ratio is currently 3.9 days.

Harvard Bioscience Stock Up 1.1 %

HBIO opened at $1.77 on Friday. Harvard Bioscience has a fifty-two week low of $1.70 and a fifty-two week high of $4.93. The company has a market capitalization of $77.21 million, a P/E ratio of -5.36 and a beta of 1.27. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.06 and a quick ratio of 0.91. The firm’s fifty day moving average price is $2.09 and its two-hundred day moving average price is $2.50.

Institutional Trading of Harvard Bioscience

Several institutional investors have recently made changes to their positions in HBIO. GSA Capital Partners LLP bought a new position in Harvard Bioscience during the third quarter worth about $30,000. SG Americas Securities LLC acquired a new position in shares of Harvard Bioscience in the 3rd quarter worth approximately $36,000. Avior Wealth Management LLC lifted its position in shares of Harvard Bioscience by 1,118.1% during the 3rd quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock worth $39,000 after buying an additional 13,373 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in Harvard Bioscience in the 2nd quarter valued at $40,000. Finally, Landscape Capital Management L.L.C. bought a new stake in Harvard Bioscience in the third quarter valued at $50,000. 80.87% of the stock is currently owned by institutional investors and hedge funds.

About Harvard Bioscience

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.